NCT07101328
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07101328
Title A Study of LY4152199 in Participants With Previously Treated B-cell Cancers and Leukemia (BAF-FRontier-1)
Acronym BAF-FRontier-1
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | GBR | FRA | ESP | DNK | DEU | CAN | AUS


No variant requirements are available.